Submit your email to push it up the queue
Alere Medical, Inc., a prominent player in the healthcare industry, is headquartered in the United States and operates extensively across various regions. Founded in 1998, the company has established itself as a leader in point-of-care diagnostics, focusing on innovative solutions that enhance patient care and streamline clinical workflows. Alere's core offerings include rapid diagnostic tests and monitoring devices, which are distinguished by their accuracy and speed, enabling healthcare professionals to make informed decisions swiftly. The company has achieved significant milestones, including numerous regulatory approvals and partnerships that bolster its market position. With a commitment to advancing medical technology, Alere Medical continues to be a trusted name in the diagnostics sector, recognised for its contributions to improving patient outcomes globally.
How does Alere Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Alere Medical, Inc.'s score of 72 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Alere Medical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that includes UnitedHealth Group Incorporated, from which it inherits climate-related commitments and performance metrics. As a merged entity, Alere Medical's climate initiatives and reduction targets are aligned with those of UnitedHealth Group. However, specific reduction targets or achievements for Alere Medical itself have not been disclosed. The company does not appear to have set Science-Based Targets Initiative (SBTi) reduction targets or other documented climate pledges. In the context of climate commitments, Alere Medical is expected to adhere to the sustainability and emissions reduction strategies established by its parent company, UnitedHealth Group. This includes a focus on reducing emissions across various scopes, although specific details regarding these initiatives have not been provided for Alere Medical. Overall, while Alere Medical, Inc. does not present its own emissions data or reduction targets, it is positioned within a larger framework of corporate responsibility and climate action through its relationship with UnitedHealth Group.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alere Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.